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Abstract  
As cancer detection and treatment improves, people with cancer diagnoses are living longer. 
Cancer as a chronic illness has led to new demands to manage the side effects of the disease. In 
cancer patients, one of the most common symptoms is sleep disturbance and fatigue. Sleep is 
critical for providing restorative, protective, and energy-conserving functions that are imperative 
for human life. The purpose of this study is to be able to describe sleep trajectories and symptom 
burden for hospitalized patients with advanced cancer over time. The Unpleasant Symptom 
Theory was used to explain how distressing symptoms, for example sleep disturbances, are a 
result of various factors. This study is a secondary analysis of a multi-site, prospective, 
observational study of palliative care consults in hospitalized patients with advanced cancer. 
Participants in this study included patients 18 years or older admitted to an acute care unit with 
advanced cancer that did not fit any of the exclusion criteria. The Condensed Memorial 
Symptom Assessment Scale (CMSAS) was used to assess sleep disturbances in study 
participants as well as co-occurring symptoms of pain, worry, nervousness, sadness, and lack of 
energy. We reviewed 12 adults that had complete data. Sleep disturbance was present in 90% of 
days measured and the patients endorsed an average of 5.5 concurrent symptoms when sleep 
disturbance was endorsed. Results from this study are consistent findings with others involving 
patients with cancer.  
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I. Statement of Problem 
Introduction  
On average, forty percent of Americans will at some point in their lifetime develop 
cancer, and nearly 600,000 American deaths will occur annual from this condition (May et al., 
2016). As clinical care and research advances, cancer is being detected, diagnosed, and treated 
earlier. These improvements have led to more individuals surviving the initial period and to 
cancer being managed as a chronic, long-term illness (McCorkle et al., 2011). The disease itself 
as well as the forms of treatment cause a high symptom burden in patients, with sleep problems 
rated one of the most bothersome symptoms that cancer patients experience (Otte et al., 2015).  
Background  
Sleep is critical for providing restorative, protective, and energy-conserving functions 
that are imperative for human life (Matthews et al., 2016). Lack of sleep, whether due to 
difficulty initiating sleep or problems maintaining sleep itself, interrupts normal functioning. 
Leaving these sleep problems uncontrolled can lead to a decrease in neurological abilities which 
in turn decreases one’s quality of life (Coe, et al., 2018).  
Chronic sleep loss is a serious health issue that affects millions of people (Basner, 
Dinges, Ma, Rao, 2015). Impacts on the brain from lack of sleep can be detrimental as it effects 
attention, memory, and learning. Patients experiencing poor sleep typically also face other 
burdensome symptoms. Feelings of pain, dyspnea, anxiety, and depression can further perpetuate 
sleep disturbance in already ill patients (Basara, Capezuti, Krieger, Woody, Zadeh, 2018).  
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Despite the importance of sleep, especially in ill patients, hospitals negatively impact 
sleep hygiene. Frequent periods of wakefulness by care providers, noise level, and light all add to 
sleep disruption in a hospital setting (Missildine, 2008). 
Pain, fatigue, and sleep disturbance often exist as co-occurring symptoms and even more 
so in those with cancer (Coe, et al., 2018). These symptoms negatively affect quality of life and 
can furthermore negatively impact prognosis (Coe, et al., 2018).  
 Patients with advanced cancer may experience episodes of acute illness that require 
hospitalization. Hospitalized acutely ill patients, such as those with cancer, are at the highest risk 
for nonrestorative sleep leading to poor patient outcomes (Stewart & Arora, 2018). With rates of 
chronic cancer increasing, the need to care for the associated symptom burden, including sleep, 
is critical. Despite the acknowledgement that levels of sleep disturbance in advanced cancer 
patients is high, little advancements have been made to manage these issues (Coe, et al., 2018).   
More evidence is necessary to guide management of this disturbance.  
 
Purpose of Study 
 The purpose of this study is describe sleep problems and the co-occurring symptom 
burden for hospitalized patients with a diagnosis of cancer. 
Significance of Study 
 The increase in cancer survivorship has led to an increased need to care for the symptom 
burden that accompanies advanced cancer as it transitions from an acute to a chronic illness.  
Theoretical Framework  
The Unpleasant Symptom Theory, demonstrated in Figure 1 below, was created by 
Elizabeth Lenz, a nurse researcher involved in clinical practice (Lenz, Pugh, Miligan, Gift, & 
Suppe, 1997). The theory is made up of three components including the symptoms experienced, 
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the factors influencing the symptoms, and what these factors and symptoms result in (Lopes-
Junior, et al., 2015). The influencing elements include physiologic, psychologic, and situational 
factors. The theory explains how distressing symptoms, for example sleep disturbances, are a 
result of various factors. The theory also demonstrates how co-occurring symptoms influence 
performance. The framework displays that in order to alleviate symptoms, interventions should 
also be aimed at the factors that alter them. This in turn results in better performance.  
 
Figure 1. Unpleasant Symptom Theory 
 
Research Question 
What is the rate of sleep disturbance and concurrent symptom burden in patients with cancer?   
Definition of Terms  
Advanced Cancer: Diagnosis of cancer that is unlikely to be cured, the patient will have to live 
with as a chronic illness. 
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Insomnia: a report by an individual of difficulty sleeping. 
Sleep: A time where eyes are closed, muscles are relaxed, allowing the mind and body to restore 
itself. 
Sleep Disruption: Awakenings in the night. 
Sleep Latency: When it takes a longer length of time to fall asleep.   
Symptom: a feature, either physical or mental, that is apparent to the patient and a result of a 
disease. 
 
 
II. Review of Literature 
Overview 
The purpose of this literature review was to investigate the association between sleep and 
cancer. Using the key words ‘cancer’, ‘oncology’, ‘sleep,’ ‘sleep disturbance, ‘sleep quality,’ 
with the following search engines: Google Scholar, PubMed, and CINHAL, the review of 
literature was conducted. Dates of articles were restricted to the past 10 years, 2008-2018, to 
keep the information gathered up to date. Overall, numerous studies have looked into the 
symptom burden of cancer patients and sleep disturbances were found amongst many of the 
participants in the articles examined. 
Sleep is critical. It provides for providing restorative, protective, and energy-conserving 
functions that are imperative for human life (Matthews et al., 2016). Disturbance in sleep can 
lead to disruption in behavioral processes as well as fatigue. Fatigue is a feeling of tiredness or 
weakness. This is a subjective feeling that, in the average healthy person, is caused by energy 
expenditure being greater than the amount of sleep that was had, often caused by poor sleep. 
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Poor sleep is determined by a number of present symptoms. Sleep disruptions throughout the 
night, sleep latency, an overall decreased number of hours of sleep, and the inability to function 
during the day without napping are all signs of dysfunctional sleep (Otte, et al., 2015). A sleep 
disorder effects nearly 70 million Americans suffer from (Stewart & Arora, 2018). Of those 
affected, a large majority of the sleep disturbance is caused by illness and hospitalization.  
Sleep Disturbance in the Hospital Setting  
 Being in a hospital environment often interferes with a proper sleep cycle. Between 
frequent visits from care providers, noise, and light disruptions, sleep barriers are common in this 
setting. These disturbances in the hospital that lead to acute sleep loss have been associated with 
overall poor patient outcomes and poor patient experience (Stewart & Arora, 2018).  
Noise is one of the largest factors in sleep disturbance in a healthcare setting. In a 
publicly reported quality measure on noise, 42% of hospitalized patients considered their room to 
not be quiet overnight and ranked it as the worst of patient experience measures (Stewart & 
Arora, 2018). Much of the noise came from factors that were modifiable such as staff 
conversation (Stewart & Arora, 2018). Patients failing to receive quiet rooms often demonstrated 
clinical outcomes including, but not limited to, increased stress response and increased 
physiologic arousal adding to sleep disturbance (Stewart & Arora, 2018). 
Sleep Disturbance in Cancer  
 Due to underreporting, poor evaluation, and various types of sleep measures, both the 
severity and prevalence of sleep disturbance in patients with cancer is challenging to determine 
(Matthews et al., 2016). Despite the lack of complete data on sleep in cancer, the complaints of 
poor sleep are common in cancer patients. These complaints included difficulty falling asleep or 
staying asleep as well as frequent and prolonged awakenings overnight (Fiorentino & Ancoli-
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Israel, 2007). The causes of these issues are multifactorial, resulting from various environmental 
factors, patient characteristics, and the disease, cancer, itself. Overall the rates of sleep 
disturbance in those with cancer are double that of the general population interfering with a 
patient’s quality of life (Fiorentino & Ancoli-Israel, 2007).  
Additionally, psychiatric issues have an effect on sleep. Problems such as anxiety and 
depression are often related to increased sleep disturbances in patients (Stewart & Arora, 2018).  
In an evaluation of fifty lung cancer patients, it was concluded that high levels of sleep 
dysfunction as well as other combined symptoms were present (Nishiura, Tamura, Nagai, 
Matsushima, 2015). The Athens Sleep Insomnia Scale (AIS) and Hospital Anxiety and 
Depression Scale (HADS) were used to assess the patients as well as asking about quality of life, 
pain, and overall fatigue. The results displayed that 56% of participants were facing sleep 
disturbance. The poor sleep correlated with high levels of anxiety and depression, higher pain 
levels, higher fatigue scores, and lower quality of life (Nishiura, Tamura, Nagai, Matsushima, 
2015). The correlation between poor sleep and high levels of anxiety and depression could be 
due to the high levels of psychiatric symptoms leading to sleep disruption.  
Pain is a major symptom associated with chronic illnesses. The frequently reported 
feeling of pain often experienced by cancer patients is a major cause of nighttime awakenings 
and overall poor sleep (Stewart & Arora, 2018). Pain is often treated with opioids. The use of 
opioids, although not well studied, has displayed a decrease in REM sleep causing a person who 
is using these medications to feel even less rested (Fiorentino, Ancoli-Israel, 2007). In a study of 
symptom burden done on adults receiving chemotherapy with advanced cancer, pain, sleep 
disturbance, and fatigue levels were high. This correlated with higher levels of stress and 
therefore higher levels of interference of daily life (Coe, et, al., 2018).  
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The disease of cancer itself has an effect on sleep. Both radiation and chemotherapy, 
treatments of cancer, have been known to create sleep issues as side effects from altered levels of 
inflammatory cytokines (Howell, et al., 2014). The distress associated with this chronic illness 
also effects the sleep-wake cycle. Maladaptive sleep behaviors then develop as a result of the 
long0term sleep disturbance which further perpetuates the issue (Fiorentino, Ancoli-Israel, 
2007). 
 Cancer patients often experience insomnia, a subjective report of poor sleep. A study was 
done using a telephone help line to measure the prevalence of this disturbance using the 
Insomnia Severity Index. Out of the 500 patients surveyed, 59.4% reported some symptoms of 
insomnia with 27% of them stating that it was moderate to severe levels. This study concluded 
that these sleep disturbance issues are common and support is necessary for those affected 
(Morris et al., 2015). It was found that sleep pills did prove effective in inducing sleep in those 
facing disturbance, but they did not work well enough to improve overall sleep quality (Nishiura, 
Tamura, Nagai, Matsushima, 2015). 
 Similarly, a study done by Mercadante et al. (2015) found similar prevalence of sleep 
disturbances in patients with advanced cancer. Of the 820 patients surveyed, 60.8% of those that 
participated had consistent moderate-maximum sleep disturbance. These results were collected 
over a period of six months using the Athens Insomnia Scale and the Hospital Anxiety and 
Depression Scale (HADS). The use of the HADS displayed a positive correlation between sleep 
depression and anxiety and depression scores. The use of hormone therapy, opioids, and 
corticosteroids in patients also displayed higher disturbance in sleep. These results concluded 
that sleep issues are common in cancer patients and careful examinations should be done in order 
to treat the disturbances (Mercadante et al., 2015).  
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Measuring Sleep  
The Pittsburgh Sleep Quality Index (PSQI) is a the most commonly used measurement 
tool for assessing sleep (Mollayeva et al., 2016). Searching for ‘Pittsburgh quality sleep index’ 
on PubMed resulted in 3,280 articles that used this tool. The PSQI was created in the 1980s to 
standardize the measure of sleep quality. It is aimed to provide both validity and reliability as 
well as help to discriminate “good” versus “poor sleepers. It was created in order to give patients 
something easy to complete that is also easy to interpret by researchers/clinicians (Mollayeva et 
al., 2016). 
Actigraphy is another tool used for gauging sleep. It is a non-invasive and cost-effective 
monitor that tracks movement in order to analyze sleep-wake cycles (Roebuck et al., 2013). It 
can track movement 24 hours a day, and using the assumption that people move more while 
awake, it assesses sleep. Movement decreases with sleep and continues to decrease as people 
progress into the deepest stages of sleep (Massimiliano et al., 2015). Both the convenience and 
validity of actigraphy has led it to be the most accurate option to record sleep as an alternate to 
polysomnography (Van De Water et al., 2010). 
Polysomnography (PSG) is considered the gold standard for sleep measurement. It is 
used widely to evaluate abnormal sleep to aid in diagnosing disorders through the measurement 
of brain waves, eye movement, muscle tension, respiration, heart rate, and leg movements 
(Fiorentino, & Ancoli-Israel, 2007). However, due to cost and user-related difficulties it is often 
impractical in a clinical environment which is why alternatives such as actigraphy and the PSQI 
exists (Van De Water et al., 2010).  
Although all of these are examples of measuring sleep, each tool does so in a different 
way. The PSQI is a subjective self-report whereas actigraphy and polysomnography are 
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examples of objective and direct measuring. The PQSI is just one example collecting subjective 
sleep data as well as the Athens Sleep Insomnia Scale and the Condensed Form of the Memorial 
Symptom Assessment Scale.  
Gaps in Literature 
 In conducting the literature review, numerous areas of knowledge were lacking involving 
both sleep and cancer, and general sleep in the hospital setting. There is insufficient information 
regarding sleep loss in hospitalized patients. Often, studies focus only on measuring general 
symptoms of sleep. The underlying sleep disorders themselves are not always acknowledged. 
Underreporting and overall lack of assessment also leads to the gaps that exist in understanding 
and being able to better deal with sleep disruptions in patients.  
Chapter Summary  
 This review of literature was created to describe what current literature exists about sleep 
and cancer. It discusses the prevalence, causes, and perpetuating factors of the issue. It also 
identifies what gaps still exist in regard to underreporting and lack of assessment on sleep in 
cancer patients. With the number of people living with cancer as a chronic illness growing, 
treatment of symptom burden is becoming more prevalent and thus future studies are warranted 
in order to provide best evidenced-based care for patients. 
 
III. Methodology  
Research Design  
This study is a secondary analysis of an NIH-funded prospective trial of an intervention 
to improve communication between nurses and their critically ill patients. The focus for this 
study was in the number of concurrent symptoms with sleep disturbance present. A common 
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cancer symptom cluster is sleep disturbance, pain, fatigue, depression, and anxiety, so we 
selected the variables “pain”, “lack of energy”, “sadness”, “worried”, and “nervousness” from 
the Condensed Memorial Symptom Assessment Scale.  
Population and Sample Design  
This study was conducted in 2 Intensive Care Units (ICUs) with 89 endotracheal 
intubated and mechanically ventilated, critically ill adults (Happ, et al., 2014; Tate, et al., 2013). 
Participants were over 21 years of age, able to understand English, were able to be aroused at 
baseline, and nonspeaking due to endotracheal intubation. Informed consent was obtained from 
participants or their legally authorized representative. We obtained approval from The Ohio State 
University Institutional review board (IRB) for a secondary analysis of a subset of this data that 
was specifically in participants with cancer. We selected a subset of patients that had a cancer 
diagnosis given our aim of describing sleep and concurrent symptoms in patients with cancer.  
Data Collection Procedures  
 Once informed consent was obtained, data collectors performed a baseline assessment of 
symptoms using the Condensed Form of the Memorial Symptoms Assessment Scale (CMSAS) 
(Chang, Hwang, Kasimis, & Thaler, 2004). Follow-up symptom assessment was conducted once 
per day for the following 2 days. Since participants were non-verbal, they pointed to responses 
on the CMSAS indicating the presence or absence of each symptom. 
Data Collection Instrument 
We were particularly interested in sleep, so data was collected on sleep quality at baseline 
and during the next 2 days. These daily patient assessments were completed using the CMSAS. 
This is a 14-item scale, rated on a 5-point system. It measures the presence, frequency, and 
amount of distress associated with various symptoms including energy, appetite, pain, dry 
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mouth, weight loss, drowsiness, shortness of breath, constipation, difficulty sleeping, difficulty 
concentrating, nausea, worrying, feeling sad, and feeling nervous (Chang, Hwang, Kasimis, & 
Thaler, 2004). The Memorial Symptom Assessment Scale (MSAS) compared to other 
questionnaires is a valid and reliable instrument (Browall, Sarenmalm, Nasic, Wengström, & 
Gaston-Johansson, 2013). This was determined by a study of 206 participants with cancer who 
received the Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983), the 
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire 
(EORTC) (Montazeri, et al., 1999). And the MSAS (Chang, Hwang, Kasimis, & Thaler, 2004). 
Results concluded that the use of the Memorial Symptom Assessment Scale has both convergent 
validity and consistency (Browall, Sarenmalm, Nasic, Wengström, & Gaston-Johansson, 2013). 
Data Analysis  
Descriptive statistics including percentages and means, were used to describe the 
presence of specific symptoms as well as the average symptom burden experienced.  
 
IV. Results  
 The first 30 patients were excluded from analysis due to a lack of sleep data leaving us 
with 12 patients that had complete data. We reviewed symptom data for these patients with a 
cancer diagnosis who were mechanically ventilated. The average age was 58 with a range of 36-
80 years old. The majority of patients were female and white at 67% female and 92% white. All 
participants were on mechanical ventilation for an average of 33 days, with a minimum of 4 days 
and a maximum of 88 days. These patients were critically ill as indicated by the average 
APACHE III score of 48 with a minimum of 23 and a maximum of 70.  See table 1.  
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 The first 30 patients were excluded from the analysis due to a lack of sleep data leaving 
us with 12 patients that had complete data. We reviewed symptom data for these patients with a 
cancer diagnosis who were mechanically ventilated. The average age was 58 (sd = 13.2, range = 
36-80 years old). The majority of patients were female (n = 8, 67% of study population) and 
white (n = 11, 92% of study population). All participants were on mechanical ventilation for an 
average of 33 days (sd = 28.3, range = 4-88 days). These patients were critically ill as indicated 
by the average APACHE III score of 48 (sd = 14.2, range = 23 – 70 Score; See Table 1).  
 Results display a high level of symptom burden. Patients endorsed difficulty sleeping on 
90% of days measured.  In addition to sleep, pain was present in 80% of the days measured, 
worrying in 88% of days, sadness in 100% of days, nervousness in 94% of days, and lack of 
energy in 80% of days measured. Interestingly, the results varied based on the order questions on 
the CMSAS were asked. Those that were asked early in the interview to rate such variables as 
“pain”, “difficulty sleeping”, and “lack of energy” have a greater percentage of responses than 
those who rated those items later (as participants became less responsive to questions; See Table 
2). For those patients that endorsed difficulty sleeping, there was an average of 5.5 concurrent 
symptoms also endorsed (sd = 0.642, range = 5 – 7). This is consistent with other studies, 
displaying the severity of the patient’s symptom burden and disease (See Table 3). 
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Table 1. Demographics 
Variable N (%)   
Sex (female) 8 (67)   
Race (white) 11 (92)   
 Mean (SD) Minimum Maximum 
Age 58.08 (13.2) 36 80 
MV days 33 (28.3) 4 88 
APACHE III 
(Knaus, et al., 
1991) 
48 (14.2) 23  70 
 
 
 
Table 2. Symptoms 
Symptom % (yes/n) 
Difficulty sleeping 90 (17/19) 
Pain 80 (16/20) 
Worrying 88 (15/17) 
Sad 100 (17/17) 
Nervous 94 (16/17) 
Lack of Energy 80 (16/20) 
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Table 3. Mean number of concurrent symptoms when sleep disturbance present 
Minimum Maximum Mean 
Standard 
Deviation 
5 7 5.53 0.642 
 
 
V. Conclusions and Recommendations 
Summary of Findings  
Results from this study displayed consistent findings with other studies involving patients 
with cancer. Hospitalized patients with cancer continue to have a high symptom burden 
especially when symptom disturbances are present.  This study found sleep disturbance present 
in 90% of the days measured. Additionally, when sleep disturbance was endorsed, there was also 
an average of 5.5 concurrent additional symptoms being experienced. With the complex nature 
of concurrent symptoms, it is difficult to ascertain if their symptoms were cancer specific or due 
primarily to the hospitalization. 
Implications of Study 
The results of this study are applicable to the clinical setting because data shows that 
there is a relationship between sleep disturbance and the presence of other unpleasant symptoms. 
Further exploration of management of sleep in the hospital setting is warranted to improve 
overall symptom management.  
Recommendations  
Further studies with larger sample sizes that compare hospitalized patients without a 
diagnosis of cancer to hospitalized patients with a diagnosis of cancer are needed. This will help 
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to determine if it is the hospitalization that is related to the symptom burden or if it is the disease 
of cancer itself. Additionally, it would be helpful to identify if certain symptoms are treated, does 
it affect the entire symptom burden experience.  
 
VI. Appendix  
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